|
- Etelcalcetide - Wikipedia
Etelcalcetide, sold under the brand name Parsabiv, is a calcimimetic medication for the treatment of secondary hyperparathyroidism in people undergoing hemodialysis It is administered intravenously at the end of each dialysis session
- Etelcalcetide Uses, Side Effects Warnings - Drugs. com
Parsabiv (etelcalcetide) is an intravenous (IV) injection used to treat secondary hyperparathyroidism in adults with chronic kidney disease (CKD) who are on hemodialysis Parsabiv binds to and activates calcium-sensing receptors (CaSRs) in parathyroid tissue, mimicking the action of calcium
- Parsabiv (etelcalcetide) dosing, indications, interactions, adverse . . .
Indicated for patients with chronic kidney disease (CKD) on hemodialysis cinacalcet, etelcalcetide Either increases effects of the other by pharmacodynamic synergism Contraindicated
- Parsabiv (etelcalcetide) - Uses, Side Effects, and More
Parsabiv (etelcalcetide) is commonly used to treat hyperparathyroidism in people who have chronic kidney disease (CKD) and are on dialysis Hyperparathyroidism is a condition that results in high
- Etelcalcetide (intravenous route) - Mayo Clinic
Etelcalcetide injection is used to used to treat secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH)
- Etelcalcetide | C38H73N21O10S2 | CID 71511839 - PubChem
Etelcalcetide is a calcimimetic agent that allosterically modulates the calcium-sensing receptor (CaSR) Etelcalcetide binds to the CaSR and enhances activation of the receptor by extracellular calcium Activation of the CaSR on parathyroid chief cells decreases PTH secretion
- Etelcalcetide: Uses, Interactions, Mechanism of Action - DrugBank Online
Etelcalcetide is a calcimimetic agent that allosterically modulates the calcium-sensing receptor (CaSR) Etelcalcetide binds to the CaSR and enhances activation of the receptor by extracellular calcium Activation of the CaSR on parathyroid chief cells decreases PTH secretion
- Etelcalcetide Injection: MedlinePlus Drug Information
Etelcalcetide injection is used to treat secondary hyperparathyroidism (condition in which the body produces too much parathyroid hormone [PTH; natural substance needed to control the amount of calcium in the blood]) in adults with chronic kidney disease (condition in which the kidneys stop working slowly and gradually) who are being treated
|
|
|